Age-stratified outcome of a genotype-guided dosing algorithm for acenocoumarol and phenprocoumon-Reference-Cited by-同舟云学术

Age-stratified outcome of a genotype-guided dosing algorithm for acenocoumarol and phenprocoumon

Published:2017-02-17 Issue:3 Volume:15 Page:454-464
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Zhang Y.¹,de Boer A.¹,Verhoef T. I.²,van der Meer F. J. M.³,Le Cessie S.⁴⁵,Manolopoulos V. G.⁶⁷,Maitland-van der Zee A. H.¹,

Affiliation:

1. Division of Pharmacoepidemiology and Clinical Pharmacology; Utrecht Institute for Pharmaceutical Sciences; Utrecht University; Utrecht the Netherlands

2. Department of Applied Health Research; University College London; London UK

3. Department of Thrombosis and Hemostasis; Leiden University Medical Center; Leiden the Netherlands

4. Department of Medical Statistics and Bioinformatics; Leiden University Medical Center; Leiden the Netherlands

5. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden the Netherlands

6. Clinical Pharmacology Unit; Academic General Hospital of Evros; Alexandroupolis Greece

7. Laboratory of Pharmacology; Medical School; Democritus University of Thrace; Alexandroupolis Greece

Funder

Seventh Framework Programme

China Scholarship Council

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13601/fullpdf

Reference25 articles.

1. Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population;Garcia;Chest,2005

2. Aging and oral anticoagulant therapy using acenocoumarol;Cesar;Blood Coagul Fibrinolysis,2004

4. The association of age with dosage requirement for warfarin;Redwood;Age Ageing,1991

5. Cardiovascular drug therapy in the elderly: benefits and challenges;Fleg;Nat Rev Cardiol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?;Pharmaceuticals;2021-10-18

2. Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms;Frontiers in Pharmacology;2020-01-28

3. Distinguishing successive ancient polyploidy levels based on genome-internal syntenic alignment;BMC Bioinformatics;2019-12

4. Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring;Therapeutic Drug Monitoring;2019-04

5. Age-stratified outcome of a genotype-guided dosing algorithm for acenocoumarol and phenprocoumon;Journal of Thrombosis and Haemostasis;2017-02-17